ctxB

Cholera Toxin B subunit Recombinant
Shipped with Ice Packs
In Stock

Description

GM1 Ganglioside Binding

CTxB binds with high affinity to GM1, a glycosphingolipid enriched in lipid rafts . This interaction initiates:

  • Membrane Reorganization: Clustering of GM1 induces phase separation, stabilizes ordered lipid domains (rafts), and generates membrane curvature .

  • Endocytosis: CTxB-GM1 complexes enter cells via clathrin-dependent, caveolin-dependent, or clathrin-independent pathways (e.g., CLIC/GEEC) .

Intracellular Trafficking

After internalization, CTxB undergoes retrograde transport to the endoplasmic reticulum (ER), enabling CTA’s cytosolic entry and ADP-ribosylation of Gαs . Trafficking kinetics depend on GM1’s ceramide structure .

Immunomodulation

CTxB triggers MAPK/NFκB signaling, promoting anti-inflammatory responses. This property underpins its use as a vaccine adjuvant .

Membrane Curvature Induction

CTxB generates negative membrane curvature via cooperative GM1 clustering. Simulations show this process involves:

  • Lipid compression and crosslinking .

  • Long-range (>20 nm) attractive forces between CTxB pentamers .

Phase-Dependent Binding

CTxB preferentially binds GM1 in liquid-ordered (Lo) membrane phases, but molecular dynamics simulations suggest stronger hydrogen bonding in liquid-disordered (Ld) environments . Experimental data confirm rapid Lo-phase localization in GUVs and GPMVs .

Mutagenesis Insights

The H57A mutant retains GM1 binding but loses toxicity and immunomodulatory activity. Structural analysis reveals a 7-Å loop displacement occluding the central pore, disrupting interactions essential for cellular entry .

Research Tools

  • Membrane Raft Marker: CTxB stabilizes GM1-rich nanodomains, though it actively modifies membrane organization rather than passively labeling rafts .

  • Curvature Sensor: Used to study membrane tubulation and endocytic carrier formation .

Therapeutic Potential

  • Vaccine Adjuvant: Enhances antigen uptake and immune responses .

  • Autoimmune Therapy: Suppresses proinflammatory pathways via GM1-mediated signaling .

Experimental Considerations

  • GM1 Variability: Binding and trafficking outcomes depend on GM1’s acyl chain structure and membrane lipid composition .

  • Multivalency Effects: Monovalent CTxB mutants fail to cluster GM1 or stabilize rafts .

Product Specs

Introduction

Cholera Toxin B subunit (ctxB), produced by the bacterium Vibrio cholerae, is the protein complex responsible for the severe watery diarrhea associated with cholera infection. This toxin comprises six protein subunits: one A subunit and five B subunits, forming an AB5 structure. The B subunit binds to target cells, while the A subunit activates a G protein, which in turn activates adenylate cyclase. Five B subunits arrange themselves in a ring, with the A subunit's A1 portion (CTA1) acting as an enzyme that modifies G proteins and the A2 chain (CTA2) forming a helix nestled within the B subunit ring's central pore.

Description

Recombinant Cholera Toxin B subunit, produced in E. coli, is a single, non-glycosylated polypeptide chain with 103 amino acids and a molecular weight of 11.6 kDa. This ctxB product is purified using proprietary chromatographic techniques.

Physical Appearance

A sterile, colorless solution.

Formulation

ctxB is provided in a 0.2 µm filtered solution containing 5mM PB (pH 7.0), 75mM NaCl, and 50% glycerol.

Stability

For short-term storage (up to 2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.

Purity

Purity exceeds 98.0%, as determined by: (a) RP-HPLC analysis and (b) SDS-PAGE analysis.

Synonyms

Cholera enterotoxin subunit B, Cholera enterotoxin B chain, Cholera enterotoxin gamma chain, Choleragenoid, ctxB, toxB.

Source

Escherichia Coli.

Amino Acid Sequence

TPQNITDLCA EYHNTQIYTL NDKIFSYTES LAGKREMAII TFKNGAIFQV EVPGSQHIDS QKKAIERMKD TLRIAYLTEA KVEKLCVWNN KTPHAIAAIS MAN.

Q&A

What is ctxB and what role does it play in cholera pathogenesis?

ctxB encodes the B-subunit of cholera toxin (CTxB) in Vibrio cholerae. The toxin consists of one A-subunit (encoded by ctxA) and five identical B-subunits that form a pentameric ring. This structure is essential for the pathogenesis of cholera, as CTxB binds to GM1 gangliosides on intestinal epithelial cells, allowing the A-subunit to enter cells and activate adenylate cyclase. This activation leads to massive fluid secretion into the intestinal lumen, causing the profuse watery diarrhea characteristic of cholera .

How does CTxB interact with cell membranes?

CTxB is not merely a passive membrane binder but actively modifies membrane properties. Research has shown that CTxB can drive phase separation, induce membrane curvature, stabilize lipid rafts, stimulate its own internalization, and redirect GM1 into different intracellular trafficking pathways. These activities depend on CTxB's ability to bind multiple GM1 molecules simultaneously. Studies demonstrate that CTxB requires binding to at least two GM1 molecules to generate membrane curvature, as confirmed by comparing pentavalent wild-type CTxB with monovalent mutant CTxB that can bind only a single GM1 .

What structural features of CTxB enable its membrane-modifying activities?

The membrane-modifying abilities of CTxB stem from several key structural features:

  • Its homopentameric structure with five identical subunits arranged in a ring

  • GM1 binding pockets located on the perimeter of the pentamer

  • Binding pockets elevated above the membrane-binding surface

What PCR-based methods are most effective for detecting and analyzing ctxB genes?

Several PCR-based methods have been optimized for ctxB analysis:

Conventional PCR Protocol:

  • Reaction mixture (25 μL total):

    • DNA template (100 ng): 1 μL

    • Forward primer (10 pmol): 1 μL

    • Reverse primer (10 pmol): 1 μL

    • Master mix (2X): 12.5 μL

    • Deionized water: 7 μL

  • Cycling conditions:

    • Initial denaturation: 95°C for 5 minutes

    • 35 cycles: 95°C for 1 min, 53°C for 1 min, 72°C for 30 sec

    • Final extension: 72°C for 4 min

Real-Time PCR Protocol:

  • Reaction mixture (25 μL total):

    • 2x Real-Time probe master with ROX: 12.5 μL

    • Forward/reverse primers (10 pmol each): 1 μL each

    • Dual-labeled DNA probe (10 pM): 2 μL

    • DNA template (100 ng): 2.5 μL

    • PCR-grade water: 6 μL

  • Cycling conditions:

    • Initial denaturation: 95°C for 2 minutes

    • 40 cycles: 95°C for 15 sec, 53°C for 30 sec, 72°C for 30 sec

    • Final extension: 72°C for 5 min

Double Mismatch Amplification Mutation (DMAMA) PCR is particularly useful for detecting specific ctxB genotypes based on known mutations, using primers with deliberate mismatches near the 3' end to selectively amplify specific alleles .

How can high-resolution melting curve (HRM) analysis be used to study ctxB mutations?

HRM analysis has emerged as a powerful technique for studying ctxB mutations because it's simple, fast, and sensitive. The method works through:

  • PCR amplification using a saturating fluorescent dye (e.g., HOT FIREPol® EvaGreen®)

  • Gradually melting the PCR product from 75°C to 95°C in 0.1°C increments

  • Continuously monitoring fluorescence changes during melting

  • Analyzing melting curve shapes, which differ between variants due to:

    • GC content variations

    • Sequence length differences

    • Nucleotide substitutions

    • Heterozygosity

Research demonstrates that HRM is particularly valuable for monitoring toxigenic V. cholerae strains during outbreaks, as it can rapidly identify genetic modifications without requiring subsequent probing or sequencing. This makes it a sensitive, cost-effective tool for differentiating between different ctxB variants in clinical settings .

What sequencing approaches are most effective for analyzing ctxB genetic diversity?

For comprehensive analysis of ctxB genetic diversity, several sequencing approaches have proven effective:

Direct Sequencing of PCR Products:

  • Amplify ctxB gene fragments by PCR

  • Sequence each amplified fragment multiple times (3×) for verification

  • Analyze sequences using software like Chromas to identify variations

Comparative Sequence Analysis:

  • Align sequences from different strains

  • Identify single nucleotide polymorphisms (SNPs)

  • Detect insertions/deletions and changes in regulatory regions

  • Perform phylogenetic analyses to understand evolutionary relationships

Whole Genome Sequencing:

  • Provides comprehensive genetic context of ctxB

  • Enables identification of all genetic variations

  • Allows analysis of relationships between ctxB and other virulence genes

  • Most valuable for evolutionary studies and outbreak investigations

The choice of sequencing approach depends on research objectives, with targeted sequencing being more cost-effective for routine surveillance and whole genome sequencing providing deeper insights for evolutionary studies.

How do genetic exchanges between Classical and El Tor biotypes affect ctxB expression and function?

Genetic exchanges between Classical and El Tor biotypes create hybrid strains with altered virulence properties. These exchanges affect ctxB expression and function in several ways:

Promoter Structure Differences:
Classical and El Tor ctxAB promoters differ in the number of heptad TTTTGAT repeats in their upstream regions, which affects transcriptional regulation .

Regulatory Mechanisms:
In Classical biotype, ToxRS can directly activate ctxAB expression in a ToxT-independent manner when bile acids are present. This direct activation isn't observed in El Tor strains due to promoter differences. When genetic exchanges occur, these regulatory mechanisms can be altered, potentially changing toxin expression patterns .

Virulence Consequences:
Hybrid strains may combine advantageous traits from both parental biotypes, such as efficient colonization (El Tor) with higher toxin production (Classical). Research has shown that changes in ctxB sequences facilitate genetic exchanges between strains, potentially creating variants with enhanced virulence that contribute to recent outbreaks .

What is the relationship between ToxR regulation of ctxB and environmental sensing?

ToxR plays a sophisticated role in regulating ctxB expression in response to environmental cues:

Dual Regulatory Pathways:
ToxR can regulate ctxAB through two distinct mechanisms:

  • Indirectly through the ToxR→ToxT regulatory cascade (primary pathway)

  • Directly activating ctxAB in a ToxT-independent manner (in Classical biotype)

Bile Acid Sensing:
The direct activation pathway is particularly interesting as it requires bile acids, which are present in the human intestinal environment. The transmembrane domain of ToxR appears to interact with bile acids in the inner membrane of V. cholerae, creating a physiological sensing system independent of pH and temperature .

Biotype-Specific Effects:
Classical biotype V. cholerae shows bile acid-stimulated, ToxRS-dependent expression of cholera toxin. This stimulation is not observed in El Tor biotype strains due to differences in their ctxAB promoters. This biotype-specific response to bile acids may contribute to differences in virulence and adaptation to the host environment .

This environmental sensing mechanism likely plays an important role during natural infection, as bile acids are abundant in the human intestine where V. cholerae causes disease.

How has the evolution of ctxB variants influenced cholera epidemiology?

The evolution of ctxB variants has significantly shaped cholera epidemiology:

Emergence of Hybrid Strains:
Classical ctxB genes have been detected in El Tor biotype strains, creating hybrid variants that combine advantageous properties from both biotypes. These strains have been implicated in more severe outbreaks and changing epidemiological patterns.

Sequential Outbreaks with Mixed Alleles:
Studies have documented sequential outbreaks caused by V. cholerae strains with different ctxB alleles. For example, in Mayurbhanj district of Odisha, India, sequential outbreaks were attributed to V. cholerae O1 strains with varied ctxB genotypes .

Genetic Diversity and Virulence:
Changes in ctxB sequences facilitate genetic exchanges between strains, potentially creating new variants with enhanced virulence or transmission capabilities. Recent research indicates that various sequences of ctxB in different V. cholerae strains contain changes that enable genetic exchanges, potentially creating more virulent strains .

Monitoring ctxB diversity has become essential for predicting outbreak potential and understanding the continued evolution of V. cholerae strains with altered epidemiological characteristics.

How can we correlate ctxB genotypes with clinical severity and outbreak patterns?

Understanding the relationship between ctxB genotypes and clinical outcomes requires:

Integrated Analysis Approach:

  • Collecting clinical data on symptom severity, treatment response, and outcomes

  • Isolating and genotyping V. cholerae strains from patients

  • Sequencing ctxB and analyzing genetic variations

  • Performing statistical analyses to identify correlations

Observed Patterns:

  • Classical ctxB variants typically produce more toxin than El Tor variants

  • Hybrid strains with Classical ctxB in an El Tor background often cause more severe disease

  • Sequential outbreaks in specific regions have been linked to shifts in predominant ctxB variants

Research Application:
This correlation analysis can inform treatment strategies, predict outbreak severity, and guide public health interventions during cholera epidemics.

What molecular surveillance strategies are most effective for tracking ctxB variants?

Effective molecular surveillance of ctxB variants requires a multi-tiered approach:

MethodSpeedCostResolutionApplication
Conventional PCRHighLowLowInitial screening
Real-time PCRHighMediumMediumQuantitative analysis
HRM AnalysisHighLowMediumMutation screening
DMAMA PCRHighLowMediumSpecific genotyping
SequencingMediumMediumHighDetailed analysis
PFGELowMediumMediumClonality analysis
WGSLowHighVery HighComprehensive analysis

An optimal surveillance protocol might include:

  • Initial screening with conventional or real-time PCR

  • Rapid variant discrimination using HRM analysis

  • Detailed characterization of selected isolates by sequencing

  • Periodic whole genome sequencing to detect emerging variants

Research has demonstrated that HRM analysis is particularly valuable for surveillance because it rapidly detects genetic modifications in ctxB without requiring subsequent probing or sequencing .

How can antibiotic resistance profiles be integrated with ctxB variant analysis?

Integrating antibiotic resistance data with ctxB analysis provides valuable epidemiological insights:

Methodological Approach:

  • Isolate V. cholerae from clinical samples

  • Determine antibiotic susceptibility profiles using standardized methods

  • Identify ctxB variants through PCR, sequencing, or HRM analysis

  • Detect specific resistance genes through multiplex PCR

  • Analyze correlations between ctxB variants and resistance patterns

Research Findings:
Studies have identified associations between specific ctxB variants and antibiotic resistance profiles. For example, in Mayurbhanj district outbreaks, V. cholerae O1 Ogawa biotype El Tor strains with particular ctxB variants showed resistance to co-trimoxazole, nalidixic acid, nitrofurantoin, and streptomycin .

Applications:
Understanding these associations can:

  • Help predict resistance patterns based on circulating ctxB variants

  • Inform appropriate antibiotic selection for treatment

  • Track the co-evolution of virulence and resistance determinants

  • Guide public health interventions during outbreaks

Product Science Overview

Introduction

Cholera toxin (CT) is a protein complex secreted by the bacterium Vibrio cholerae, the causative agent of cholera. The toxin is composed of two subunits: A and B. The B subunit (CTB) is responsible for binding to the host cell surface, facilitating the entry of the A subunit, which then exerts the toxic effects. Recombinant Cholera Toxin B subunit (rCTB) is a genetically engineered version of the CTB, produced without the toxic A subunit, making it a valuable tool in research and therapeutic applications.

Structure and Function

The CTB subunit is a pentameric protein, meaning it forms a complex of five identical subunits. Each subunit binds to the GM1 ganglioside, a glycolipid found on the surface of mammalian cells. This binding is crucial for the toxin’s entry into the cells. The recombinant version of CTB retains this binding ability, allowing it to be used in various applications without the associated toxicity of the A subunit .

Production and Purification

Recombinant CTB is typically produced in bacterial or mammalian expression systems. One common method involves expressing the protein in Escherichia coli or HEK 293 cells. The recombinant protein is then purified using affinity chromatography techniques, ensuring high purity and the absence of the toxic A subunit .

Applications
  1. Vaccine Development: rCTB is used as an adjuvant in vaccines to enhance the immune response. Its ability to bind to GM1 ganglioside makes it an effective carrier for delivering antigens to the immune system.
  2. Research Tool: In neuroscience, rCTB is used for retrograde labeling of neurons. By binding to GM1 ganglioside, it can trace neuronal pathways, aiding in the study of neural connections and functions .
  3. Therapeutic Potential: rCTB has been explored for its potential in treating autoimmune diseases and inflammatory conditions. For example, recombinant fusion proteins of CTB with functional peptides have been used to deliver therapeutic peptides to intestinal epithelial cells, demonstrating anti-inflammatory effects .
Safety and Advantages

The primary advantage of using rCTB over the native toxin is the elimination of the toxic A subunit, making it safe for use in various applications. Additionally, the recombinant production ensures a consistent and high-purity product, free from contaminants associated with the native toxin .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.